Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Strawn

Showing results (11-20 of 233) with videos related to

Pageof 24
Sort By:
Journal of Child and Adolescent Psychopharmacology|November 6, 2007
Successful treatment of catatonia with aripiprazole in an adolescent with psychosisJeffrey R Strawn, Sergio V Delgado
Child and Adolescent Psychiatric Clinics of North America|May 18, 2023
Neurobiology of Treatment in Pediatric Anxiety DisordersW Thomas Baumel, Jeffrey R Strawn
Journal of the American Academy of Child and Adolescent Psychiatry|May 12, 2023
Editorial: A Better Perspective on Antipsychotic-Related Hyperprolactinemia in Children and AdolescentsJeffrey R Strawn, Thomas D Geracioti
BMC Medicine|May 23, 2020
High-quality antidepressant prescribing: please consider whether "perfection is the enemy of progress"John T Walkup, Jeffrey R Strawn
The Annals of Pharmacotherapy|July 9, 2009
Risperidone treatment of an adolescent with severe posttraumatic stress disorderBrooks R Keeshin, Jeffrey R Strawn
Child and Adolescent Psychiatric Clinics of North America|May 18, 2023
Risk Factors for Pediatric Anxiety DisordersEmily N Warner, Jeffrey R Strawn
Journal of Child and Adolescent Psychopharmacology|December 14, 2012
Treatment with adjunctive N-acetylcysteine in an adolescent with selective serotonin reuptake inhibitor-resistant anxietyJeffrey R Strawn, Shannon N Saldaña
Journal of Clinical Psychopharmacology|August 14, 2025
Fact Versus Fear: Antidepressants in Children and AdolescentsJeffrey R Strawn, John T Walkup
Journal of Child and Adolescent Psychopharmacology|March 3, 2025
Myths of Randomized Controlled Trial Analysis in Pediatric PsychopharmacologyJeffrey A Mills, Jeffrey R Strawn
Journal of Child and Adolescent Psychopharmacology|March 31, 2016
Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and InterpretationEric T Dobson, Jeffrey R Strawn
Pageof 24

Showing results (11-20 of 233) with videos related to

Sort By:
Pageof 24
Journal of Child and Adolescent Psychopharmacology|November 6, 2007
Successful treatment of catatonia with aripiprazole in an adolescent with psychosisJeffrey R Strawn, Sergio V Delgado
Child and Adolescent Psychiatric Clinics of North America|May 18, 2023
Neurobiology of Treatment in Pediatric Anxiety DisordersW Thomas Baumel, Jeffrey R Strawn
Journal of the American Academy of Child and Adolescent Psychiatry|May 12, 2023
Editorial: A Better Perspective on Antipsychotic-Related Hyperprolactinemia in Children and AdolescentsJeffrey R Strawn, Thomas D Geracioti
BMC Medicine|May 23, 2020
High-quality antidepressant prescribing: please consider whether "perfection is the enemy of progress"John T Walkup, Jeffrey R Strawn
The Annals of Pharmacotherapy|July 9, 2009
Risperidone treatment of an adolescent with severe posttraumatic stress disorderBrooks R Keeshin, Jeffrey R Strawn
Child and Adolescent Psychiatric Clinics of North America|May 18, 2023
Risk Factors for Pediatric Anxiety DisordersEmily N Warner, Jeffrey R Strawn
Journal of Child and Adolescent Psychopharmacology|December 14, 2012
Treatment with adjunctive N-acetylcysteine in an adolescent with selective serotonin reuptake inhibitor-resistant anxietyJeffrey R Strawn, Shannon N Saldaña
Journal of Clinical Psychopharmacology|August 14, 2025
Fact Versus Fear: Antidepressants in Children and AdolescentsJeffrey R Strawn, John T Walkup
Journal of Child and Adolescent Psychopharmacology|March 3, 2025
Myths of Randomized Controlled Trial Analysis in Pediatric PsychopharmacologyJeffrey A Mills, Jeffrey R Strawn
Journal of Child and Adolescent Psychopharmacology|March 31, 2016
Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and InterpretationEric T Dobson, Jeffrey R Strawn
Pageof 24